Proteins lead the way: JAK inhibitors as a new treatment option in toxic epidermal necrolysis
Saved in:
Main Authors: | Benjamin Klein, J. Michelle Kahlenberg, Johann E. Gudjonsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-024-02122-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erratum: JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
Published: (2025-01-01) -
CD4 expression controls epidermal stem cell balance
by: Nadine Brandes, et al.
Published: (2025-02-01) -
Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model
by: Shinri Sato, et al.
Published: (2025-01-01) -
Jak Walijczycy reformują swoją oświatę?
by: Janina Zawadowska
Published: (2014-09-01) -
Freestanding VO2 membranes on epidermal nanomesh for ultra-sensitive correlated breathable sensors
by: Dongha Kim, et al.
Published: (2025-02-01)